Larson Financial Group LLC Sells 743 Shares of Solventum Co. (NYSE:SOLV)

Larson Financial Group LLC lowered its position in Solventum Co. (NYSE:SOLV) by 19.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,125 shares of the company’s stock after selling 743 shares during the period. Larson Financial Group LLC’s holdings in Solventum were worth $218,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of SOLV. Copeland Capital Management LLC bought a new stake in Solventum during the third quarter valued at $26,000. Mather Group LLC. bought a new stake in Solventum during the 3rd quarter valued at approximately $27,000. EverSource Wealth Advisors LLC bought a new stake in Solventum during the 1st quarter valued at approximately $30,000. Hollencrest Capital Management bought a new position in Solventum during the 2nd quarter valued at approximately $25,000. Finally, Deseret Mutual Benefit Administrators bought a new stake in Solventum during the 2nd quarter valued at about $25,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Stifel Nicolaus initiated coverage on shares of Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price on the stock. Piper Sandler lifted their target price on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Morgan Stanley lifted their target price on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. BTIG Research initiated coverage on shares of Solventum in a research note on Thursday, September 5th. They issued a “neutral” rating on the stock. Finally, Wells Fargo & Company decreased their price target on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Friday, August 9th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $68.00.

Solventum Price Performance

NYSE SOLV opened at $72.48 on Thursday. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The company has a fifty day moving average of $70.51 and a 200 day moving average of $62.47.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.